Survival of the Fittest: Darwinian Selection Underpins Chemotherapy Resistance in AML
- PMID: 28886361
- DOI: 10.1016/j.stem.2017.08.004
Survival of the Fittest: Darwinian Selection Underpins Chemotherapy Resistance in AML
Abstract
Intratumor heterogeneity driving therapeutic resistance is a major challenge in cancer management. Recently in Nature, Shlush et al. (2017) provide a tour de force of genomics coupled to functional assays to demonstrate that resistance emerges from a pre-existing subpopulation of acute myeloid leukemia (AML) cells with a stem cell transcription program.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Tracing the origins of relapse in acute myeloid leukaemia to stem cells.Nature. 2017 Jul 6;547(7661):104-108. doi: 10.1038/nature22993. Epub 2017 Jun 28. Nature. 2017. PMID: 28658204
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
